It has been 100 years since the discovery of renin by Bergman and Tigersted
t. Since then, numerous studies have advanced our understanding of the reni
n-angiotensin system. A remarkable aspect was the discovery that angiotensi
n II (AngII) is the central product of the renin-angiotensin system and tha
t this octapeptide induces multiple physiological responses in different ce
ll types. In addition to its well known vasoconstrictive effects, growing e
vidence supports the notion that AngII may play a central role not only in
hypertension, but also in cardiovascular and renal diseases. Binding of Ang
II to the seven-transmembrane angiotensin II type 1 receptor is responsible
for nearly all of the physiological actions of AngII. Recent studies under
score the new concept that activation of intracellular second messengers by
AngII requires tyrosine phosphorylation. An increasing number of tyrosine
kinases have been shown to be activated by AngII, including the Src kinase
family, the focal adhesion kinase family, the Janus kinases and receptor ty
rosine kinases. These actions of AngII contribute to the pathophysiology of
cardiac hypertrophy and remodeling, vascular thickening, heart failure and
atherosclerosis. In this review, we discuss the important role of tyrosine
kinases in AngII-mediated signal transduction. Understanding the importanc
e of tyrosine phosphorylation in AngII-stimulated signaling events may cont
ribute to new therapies for cardiovascular and renal diseases. (C) 2000 Els
evier Science B.V. All rights reserved.